Treatment of retinopathy of prematurity with argon laser photocoagulation

M. B. Landers 3rd, C. A. Toth, H. C. Semple and L. S. Morse
Department of Ophthalmology, University of California, Davis, Sacramento 95816.

Fifteen eyes of nine infants were treated for retinopathy of prematurity by confluent photocoagulation of the avascular retina using an argon laser indirect ophthalmoscope. All treated eyes presented at or beyond threshold of stage 3 retinopathy of prematurity with "plus" disease. Three treated eyes had retinopathy of prematurity in zone I. Early complete regression of extraretinal proliferation was seen in 13 eyes. At 6 month's [corrected] minimum follow-up, 11 (73%) of the treated eyes demonstrated a favorable outcome, while four eyes (27%) progressed to an unfavorable outcome. No intraocular hemorrhages occurred during any laser treatment.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The dipeptide arg-gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu et al.
IOVS 2006;47:3151-3155.
ABSTRACT | FULL TEXT  

Near Confluent Laser Photocoagulation for the Treatment of Threshold Retinopathy of Prematurity
Rezai et al.
Arch Ophthalmol 2005;123:621-626.
ABSTRACT | FULL TEXT  

Non-ophthalmologist screening for retinopathy of prematurity
Saunders et al.
Br. J. Ophthalmol. 2000;84:130-134.
ABSTRACT | FULL TEXT  

Dopamine use is an indicator for the development of threshold retinopathy of prematurity
Mizoguchi et al.
Br. J. Ophthalmol. 1999;83:425-428.
ABSTRACT | FULL TEXT  

Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser
Pearce et al.
Br. J. Ophthalmol. 1998;82:1254-1259.
ABSTRACT | FULL TEXT  

Timing of Initial Screening Examinations for Retinopathy of Prematurity
Hutchinson et al.
Arch Ophthalmol 1998;116:608-612.
ABSTRACT | FULL TEXT